Unternehmen Cellular Biomedicine Group, Inc.
Aktien
A1JUHH
US15117P1021
CBMG
Biotechnologie
Kurzporträt
Mitarbeiterzahl: 217
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Bi Zuo Liu
CEO | Chief Executive Officer | 60 | 06.02.13 |
Yi Hong Yao
CTO | Chief Tech/Sci/R&D Officer | 57 | 01.08.15 |
Stephan Grupp
PRN | Corporate Officer/Principal | - | - |
Xia Meng
PRN | Corporate Officer/Principal | - | 26.06.17 |
Cheng Xiang Dai
PRN | Corporate Officer/Principal | - | 11.07.13 |
Li Zhang
PRN | Corporate Officer/Principal | - | - |
Andrew Chan
LAW | General Counsel | 66 | 06.02.13 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Edward Schafer
BRD | Director/Board Member | 77 | 12.10.19 |
Bi Zuo Liu
CEO | Chief Executive Officer | 60 | 06.02.13 |
Chun Kwok Au
BRD | Director/Board Member | 51 | 11.11.14 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 20 533 547 | 9 058 540 ( 44,12 %) | 1 055 499 ( 5,140 %) | 44,12 % |
Unternehmenskontakt
AbelZeta Pharma, Inc.
9605 Medical Center Drive Suite 100
20850, Rockville
+240 552 5870
http://www.cellbiomedgroup.comSektor
% 1. Jan. | Kap. | |
---|---|---|
+1.85% | 42.59 Mrd. | |
+8.20% | 40.65 Mrd. | |
+49.22% | 40.57 Mrd. | |
-12.36% | 26.77 Mrd. | |
+8.78% | 24.81 Mrd. | |
-24.53% | 18.17 Mrd. | |
+29.01% | 12.05 Mrd. | |
-3.00% | 11.7 Mrd. | |
+6.67% | 11.1 Mrd. |